body { background: #06080c; color: #e5e9f0; margin: 0; } .rw-nojs-bar { max-width: 880px; margin: 0 auto; padding: 18px 16px 14px; } .rw-nojs-bar .rw-nojs-brand { font: 700 20px/1 Inter, system-ui, sans-serif; color: #e5e9f0; text-decoration: none; } .rw-nojs-nav { max-width: 880px; margin: 0 auto; padding: 0 16px 14px; border-bottom: 1px solid #1c2230; font: 500 14px/1.4 Inter, system-ui, sans-serif; } .rw-nojs-nav a { color: #6f9bff; margin: 0 14px 6px 0; text-decoration: none; display: inline-block; } .rw-nojs-nav a:hover { text-decoration: underline; } .rw-nojs-note { max-width: 880px; margin: 12px auto 0; padding: 0 16px; font: 400 13px/1.5 Inter, system-ui, sans-serif; color: #8a93a6; } #root [data-rw-crawler] { max-width: 880px; margin: 0 auto; padding: 8px 16px 48px; font: 400 16px/1.65 Inter, system-ui, sans-serif; color: #e5e9f0; } #root [data-rw-crawler] a { color: #6f9bff; } #root [data-rw-crawler] h1 { font-size: 28px; line-height: 1.2; } #root [data-rw-crawler] h2 { font-size: 20px; margin-top: 28px; } #root [data-rw-crawler] img { max-width: 100%; height: auto; } #root [data-rw-crawler] ul { padding-left: 0; list-style: none; } #root [data-rw-crawler] li { margin: 0 0 18px; } #root [data-rw-crawler] .rw-pagination { margin: 28px 0 0; display: flex; flex-wrap: wrap; gap: 12px; align-items: baseline; } #root [data-rw-crawler] .rw-pagination strong { color: #e5e9f0; } .rw-nojs-footer { max-width: 880px; margin: 40px auto 0; padding: 22px 16px 44px; border-top: 1px solid #1c2230; font: 400 13px/1.6 Inter, system-ui, sans-serif; color: #8a93a6; } .rw-nojs-footer .rw-nojs-fcols { display: flex; flex-wrap: wrap; gap: 28px 40px; margin-bottom: 20px; } .rw-nojs-footer h2 { font-size: 11px; letter-spacing: 0.05em; text-transform: uppercase; color: #b7c0d3; margin: 0 0 8px; } .rw-nojs-footer a { color: #6f9bff; text-decoration: none; display: block; margin: 0 0 5px; } .rw-nojs-footer a:hover { text-decoration: underline; } .rw-nojs-footer .rw-nojs-legal { font: 400 12px/1.6 Inter, system-ui, sans-serif; color: #6b7384; margin: 0; } .rw-nojs-footer .rw-nojs-legal a { display: inline; } RuntimeWire Investigations Stories AI Startups Venture Products Funding Exits Models Head-to-Head About You're browsing RuntimeWire with JavaScript disabled. Articles and navigation work fully. Interactive features — search, comments, and newsletter signup — require JavaScript.

Tempus AI to Acquire Personalis for $1.5 Billion, Expanding Oncology Portfolio

The AI-enabled precision medicine firm is set to integrate Personalis' cancer testing capabilities, bolstering its position in personalized cancer care.

By Ryan Merket · Published Jul 20th, 2026, 2:22pm CT · Updated Jul 20th, 2026, 2:23pm CT

Primary source: Reuters

Why it matters

Tempus AI's $1.5 billion acquisition of Personalis reflects the accelerating convergence of AI and genomic diagnostics in oncology, as leading precision medicine firms move to consolidate specialized testing capabilities to offer more integrated, data-driven cancer care.

Illustration of Tempus AI and Personalis merging data streams with genomic test imagery to represent expanded precision in personalized cancer care.

Tempus AI Inc. announced on Monday its intent to acquire Personalis Inc. for approximately $1.5 billion, a deal aimed at integrating Personalis' cancer testing capabilities into Tempus' existing AI-enabled precision medicine and oncology portfolio, Reuters reported.…

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.

Reader comments

Conversation for this story loads after sign-in.

Sections

Investigations Stories AI Startups Venture Products Funding Exits

Publication

About FAQ Contact Editorial Policy Corrections Policy Ethics

Tools

AI Model Pricing Head-to-Head

Legal

Privacy Terms

© 2026 RuntimeWire, Inc. All rights reserved.
An independent startup and technology publication based in Austin, Texas and San Francisco, California. Send tips to tips@runtimewire.com.